Precision medicine for Glioblastoma patients: a patient-based pre-clinical platform for immuno-oncology

Medicine and Dentistry

• Immunoglobulin 100%
• Oncology 100%
• Glioblastoma 100%
• Personalized Medicine 100%
• Xenograft 41%
• Neoplasm 17%
• Tumor Microenvironment 17%
• Immunosuppressive Drug 17%
• Immunocompetent Cell 11%
• Clinical Trial 11%
• Macrophage 11%
• Immunotherapy 11%
• Tumor 11%
• Regulatory T Cell 5%
• T-Helper Cell 5%
• Innate Immunity 5%
• Temozolomide 5%
• Tumor Recurrence 5%
• Recurrent Disease 5%
• Adaptive Immunity 5%
• Intracranial Tumor 5%
• Cancer 5%
• Antigen Presentation 5%
• Hematopoietic Cell 5%
• Tumor Xenograft 5%
• Specific Tumor 5%
• Peripheral Blood Mononuclear Cell 5%
• Chlordane 5%
• Immune System 5%

Immunology and Microbiology

• Xenograft 100%
• Intravenous Immunoglobulin 100%
• Immunosuppressive Drug 37%
• Humanized Mouse 25%
• Tumor-Associated Macrophage 25%
• Immunocompetent Cell 25%
• Immunotherapy 25%
• CD34 25%
• Regulatory T Cell 12%
• Innate Immune System 12%
• Adaptive Immune System 12%
• T-Helper Cell 12%
• Human Cell 12%
• CD4 12%
• Mouse Model 12%
• Myeloid 12%
• CD11c 12%
• CD68 12%
• Hematopoietic Cell 12%
• Antigen Presentation 12%
• Peripheral Blood Mononuclear Cell 12%
• Immune System 12%

Keyphrases

• Immunosuppressive Tumor 7%
• Translational Gap 7%
• Functional Crosstalk 7%
• Dendritic-like 7%